DocDollars

Leo Pharma Inc.

NJ · United States · Reporting entity ID 100000000258

Total reported 2019–2025
$18.4M
#339 of 2,960 reporting companies — 0% of all reported industry payments
$16.6M in general payments across 217,628 records, plus $1.78M in research funding across 37 records.

How it breaks down

General payments $16,632,614
Research funding $1,780,746

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Leo Pharma Inc. reported $18.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #339 of 2,960 reporting companies. 10% of that was research funding and 90% general payments such as consulting, speaking, food and travel. 217,628 general payment records and 37 research records were filed.

Common questions about Leo Pharma Inc.

How much has Leo Pharma Inc. paid US doctors?

Leo Pharma Inc. reported $18,413,360 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $16,632,614 in general payments, $1,780,746 in research funding.

How does Leo Pharma Inc. rank among drug and device companies?

It ranks #339 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Leo Pharma Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.